tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IOVA Stock Latest News

IOVA Earnings this Week: How Will it Perform?
Pre-EarningsIOVA Earnings this Week: How Will it Perform?
2d ago
IOVA
Iovance Biotherapeutics’ Lifileucel Therapy: Promising Developments and Market Potential Justify Buy Rating
PremiumRatings
Iovance Biotherapeutics’ Lifileucel Therapy: Promising Developments and Market Potential Justify Buy Rating
3d ago
IOVA
Iovance Biotherapeutics reports clinical data from Phase 2 IOV-LUN-202 trial
PremiumThe Fly
Iovance Biotherapeutics reports clinical data from Phase 2 IOV-LUN-202 trial
3d ago
IOVA
Iovance Biotherapeutics price target lowered to $9 from $20 at H.C. Wainwright
PremiumThe Fly
Iovance Biotherapeutics price target lowered to $9 from $20 at H.C. Wainwright
8d ago
IOVA
Iovance Biotherapeutics Advances in Endometrial Cancer Treatment with Lifileucel Study
PremiumCompany Announcements
Iovance Biotherapeutics Advances in Endometrial Cancer Treatment with Lifileucel Study
9d ago
IOVA
Iovance Biotherapeutics’ Phase 3 Study: A Potential Game-Changer in Melanoma Treatment
PremiumCompany AnnouncementsIovance Biotherapeutics’ Phase 3 Study: A Potential Game-Changer in Melanoma Treatment
9d ago
IOVA
Iovance Biotherapeutics Advances TIL Therapy in Pediatric Cancer Study
Premium
Company Announcements
Iovance Biotherapeutics Advances TIL Therapy in Pediatric Cancer Study
9d ago
IOVA
Iovance Biotherapeutics’ Promising Phase 2 Study on LN-145 for Lung Cancer
Premium
Company Announcements
Iovance Biotherapeutics’ Promising Phase 2 Study on LN-145 for Lung Cancer
9d ago
IOVA
Iovance Biotherapeutics’ Innovative Cancer Study: A Potential Game-Changer?
PremiumCompany Announcements
Iovance Biotherapeutics’ Innovative Cancer Study: A Potential Game-Changer?
9d ago
IOVA
Iovance Biotherapeutics Advances Melanoma Treatment with New Study
PremiumCompany Announcements
Iovance Biotherapeutics Advances Melanoma Treatment with New Study
10d ago
IOVA
Iovance Biotherapeutics Advances Cancer Treatment with IOV-4001 Study Update
PremiumCompany Announcements
Iovance Biotherapeutics Advances Cancer Treatment with IOV-4001 Study Update
10d ago
IOVA
Iovance Biotherapeutics Updates Corporate Presentation
PremiumCompany Announcements
Iovance Biotherapeutics Updates Corporate Presentation
2M ago
8K
IOVA
Iovance Biotherapeutics reports inducement grants under NASDAQ listing rule
PremiumThe FlyIovance Biotherapeutics reports inducement grants under NASDAQ listing rule
2M ago
IOVA
Iovance Biotherapeutics Amends Sale Agreement with Jefferies
Premium
Company Announcements
Iovance Biotherapeutics Amends Sale Agreement with Jefferies
3M ago
8K
IOVA
Iovance Biotherapeutics Gains Health Canada Approval
Premium
Company Announcements
Iovance Biotherapeutics Gains Health Canada Approval
3M ago
8K
IOVA
Home Depot reports Q2 results, SoftBank invests $2B in Intel: Morning Buzz
PremiumThe Fly
Home Depot reports Q2 results, SoftBank invests $2B in Intel: Morning Buzz
3M ago
F
AS
Iovance Biotherapeutics’ Canadian Approval of AMTAGVI: A Milestone in T Cell Therapy and Stock Growth Potential
PremiumRatings
Iovance Biotherapeutics’ Canadian Approval of AMTAGVI: A Milestone in T Cell Therapy and Stock Growth Potential
3M ago
IOVA
Iovance Amtagvi receives Health Canada approval for advanced melanoma
PremiumThe Fly
Iovance Amtagvi receives Health Canada approval for advanced melanoma
3M ago
IOVA
Iovance Biotherapeutics’ Earnings Call Highlights Growth
PremiumCompany Announcements
Iovance Biotherapeutics’ Earnings Call Highlights Growth
3M ago
IOVA
Tesla disbands supercomputer team, Trade Desk Q2 spurs downgrades: Morning Buzz
PremiumThe FlyTesla disbands supercomputer team, Trade Desk Q2 spurs downgrades: Morning Buzz
3M ago
LZ
SG
Iovance Biotherapeutics price target lowered to $14 from $18 at Wells Fargo
Premium
The Fly
Iovance Biotherapeutics price target lowered to $14 from $18 at Wells Fargo
3M ago
IOVA
Iovance Biotherapeutics Reports Strong Revenue Growth in Q2 2025
Premium
Company Announcements
Iovance Biotherapeutics Reports Strong Revenue Growth in Q2 2025
3M ago
IOVA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >